Aptimmune Biologics' Angel Round

Aptimmune Biologics raised a round of funding on February 27, 2018. Investors include Arch Angels.

Aptimmune Biologics specializes in the development and application of prophylactic measures against viral diseases of swine. The company's current focus is bringing into the market effective prophylax…

Articles about Aptimmune Biologics' Angel Round: